China's NMPA Grants Breakthrough Therapy Designation for Anti-CTLA-4 Antibody Candidate Gotistobart (BNT316/ONC-392)
Designation granted for gotistobart (BNT316/ONC392) for the treatment of patients with squamous non-small cell lung cancer (sqNSCLC), an aggressive subtype of lung cancer Breakthrough Therapy designation will allow for an expedited development and...
Daewoong Pharmaceutical: Third IDMC Reaffirms Safety of Bersiporocin and Recommends Continuation of Global Phase 2 Clinical Trial
Third Independent Data Monitoring Committee (IDMC) review confirms safety and continuation of the study 94 patients enrolled out of 102 planned across Korea and the U.S. Interim baseline characteristics to be presented at the 2025 KATRD...
JinkoSolar Supplied Modules to Trinity Energy for Costco Warehouse in Washington State
CAMPBELL, Calif., Oct. 27, 2025 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. (the "Company," or "JinkoSolar") (NYSE: JKS), one of the largest and most innovative solar module manufacturers in the world, today announced that the company has supplied...
The world's first electric car without metals or minerals is launched - and it doesn't work
What happens if electric vehicles and renewable energy technologies like wind turbines and solar panels suddenly had to be produced entirely without resources from mining? eNimon, the first electric car ever made without metals or minerals, answers...
uSMART Opens Second Branch at Somerset, Broadening Access to Retail Investors with Its New Wealth Management Hub
SINGAPORE, Oct. 27, 2025 /PRNewswire/ -- On 24 October 2025, uSMART Securities (Singapore) Pte. Ltd. ("uSMART SG"), a leading fintech brokerage platform licensed by the Monetary Authority of Singapore (MAS), announced the grand opening of its second...
Ascletis to Present Study Results of ASC30 Oral Tablet, ASC30 Injection, and Combination of ASC31 and ASC47 at ObesityWeek® 2025
-Multiple posters being presented on Ascletis' small molecule and peptide obesity programs -Full analysis of 28-day multiple ascending dose study of oral GLP-1R small molecule agonist ASC30 as a late-breaking poster as well as ASC30 once-monthly...
Michelin Leads The Smart Mobility Revolution with Data and AI
HO CHI MINH CITY, Vietnam, Oct. 27, 2025 /PRNewswire/ -- Michelin is undergoing a strong transformation by applying AI and smart analytics, helping lead the smart, safe, and sustainable mobility revolution in the Industry 4.0 era. From data insights...
AI Adoption in Retail and Sustainability Redefine Consumer Spending Habits across Hong Kong and the GBA
Businesses must tailor strategies to meet evolving consumer preferences HONG KONG, Oct. 27, 2025 /PRNewswire/ -- While Chinese Mainland consumers living within the Greater Bay Area (GBA) exhibit higher confidence in artificial intelligence (AI)...